Molecular Screening for Lynch Syndrome in Southern Denmark

Completed

• Conditions: Colorectal Cancer; Lynch Syndrome; HNPCC

• Registration Number: NCT01216930
• Lead Sponsor: Vejle Hospital

Brief Summary

A clinically applicably strategy for molecular screening for Lynch Syndrome has been implemented in the Region of Southern Denmark.

Based on sequential analysis with immunohistochemistry and methylation analysis, patients with possible hereditary colorectal cancer are identified. These patients are offered genetic risk assessment and counselling.

The study hypothesis is that molecular screening will identify more patients with Lynch Syndrome than the family history alone.

Prospective data collection is performed using established clinical databases.

Detailed Description

Not available

Study Timeline

• Study Start: 2010-10
• Study First Submitted: 2010-10-06
• Study First Submitted QC: 2010-10-06
• Study First Posted: 2010-10-07
• Primary Completion: 2012-10
• Status Verified: 2015-09
• Study Completion: 2015-09
• Last Update Submitted: 2015-09-11
• Last Update Posted: 2015-09-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 2000

Inclusion Criteria

• Histological diagnosis of colorectal adenocarcinoma
• Diagnosed at one of the five departments of pathology in the region

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (3)

Department of Pathology; 🇩🇰 Vejle, Denmark

Department of Clinical Genetics; 🇩🇰 Vejle, Denmark

Department of Pahology; 🇩🇰 Svendborg, Denmark